Fundraising Fox
/Companies
Sign in

NJ BIO

Princeton, US · Delaware corporation

Find your way into NJ BIO

Sign up to see every warm intro you have to NJ BIO

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NJ BIO team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.

Advanced ManufacturingBiotechHealthtechMedical Devices

Founders & leadership

NJ
Nareshkumar JainFounder & Chief Executive Officer
JDJulien Dugal-Tessier
Julien Dugal-TessierPresident & Chief Scientific OfficerHe has over 8 years of experience as a synthetic and medicinal chemist specializing in antibody-drug conjugate design and bioconjugation, with expertise spanning metabolite identification, API development, scale-up, and contract manufacturing management.
RM
Ralf MuellerChief Business Officer
PN
Priyashri NayakChief Operating Officer
APArpit Pokharna
Arpit PokharnaChief Financial OfficerArpit Pokharna is a Chartered Accountant and Company Secretary with a management degree who has held corporate finance and business strategy roles across multiple countries and sectors, including CROs, specialty chemicals, and banking services.
SK
STEVEN KLOSKNamed on SEC filing
AG
ANJANISH GONDALIANamed on SEC filing
RG
RONALD GOLDNamed on SEC filing
CJ
CHETAN JAINNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5.6M disclosed across 1 round · 2023

▶$5.6MraisedMar 2023 · 10 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVEN KLOSKDirector
  • ANJANISH GONDALIADirector
  • RONALD GOLDDirector
  • PRIYASHRI NAYAKDirector
  • CHETAN JAINDirector
  • NARESHKUMAR JAINExecutive Officer, Director
Offering amount
$7.8M
Amount sold
$5.6M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does NJ BIO do?
NJ Bio, Inc. is a contract research and contract development and manufacturing organization (CRO/CDMO) providing integrated chemistry and biology services—including antibody-drug conjugates, bioconjugation, protein and antibody production, cell-based assays, nucleotide/oligonucleotide and mRNA synthesis, and bioanalytical work—to biotech and pharmaceutical companies. It is headquartered in Princeton, New Jersey, with additional chemistry facilities in Bristol, Pennsylvania and Mumbai, India.
Who founded NJ BIO?
NJ BIO was founded by Nareshkumar Jain.
How much funding has NJ BIO raised?
NJ BIO has disclosed $5.6M raised across 1 round.
Where is NJ BIO headquartered?
NJ BIO is headquartered in Princeton, US.